发明名称 TUMORIMMUNOTERAPI MED ANTIIDIOTYPEANTISTOFFER
摘要 The present invention relates to methods which utilize anti-idiotypic antibodies, or fragments thereof, for tumor immunotherapy or immunoprophylaxis. Monoclonal anti-idiotypic antibodies which recognize an idiotype present on a second antibody or on a T lymphocyte or on an immune suppressor factor which is directed against a defined tumor antigen, can be used for immunization against a tumor, for immune anti-tumor activation or inhibition of suppression, or for in vitro activation of lymphocytes to be used in adoptive immunotherapy. The anti-idiotypic antibodies, or fragments thereof, can also be used to monitor anti-antibody induction in patients undergoing passive immunization to a tumor antigen by administration of anti-tumor antibody. In another embodiment, administration of T lymphocytes which express an idiotype directed against a defined tumor antigen can be used to transfer delayed-type hypersensitivity to the tumor. In another method of the invention, the induction of anti-idiotypic antibodies in vivo by administration of anti-tumor antibody or immune cells or factors exhibiting an anti-tumor idiotype can be therapeutically valuable.
申请公布号 DK500888(A) 申请公布日期 1989.03.11
申请号 DK19880005008 申请日期 1988.09.09
申请人 ONCOGEN 发明人 HELLSTROM, INGEGERD;HELLSTROM, KARL ERIK;KAHN, MARIA S.;BEATON, DONNA FRANCINE;LEE, VICTOR K.
分类号 A61K;A61K38/00;A61K39/00;A61K39/395;A61P35/00;C07K16/28;C07K16/30;C07K16/42;C12N;C12N5/00;C12N15/00;C12P21/08;C12R1/91;G01N33/574;G01N33/577 主分类号 A61K
代理机构 代理人
主权项
地址